Biopharmaceuticals Dominate Healthcare-Related InvestmentHealthcare received 18% of all venture capital investment during the third quarter of 2012, dropping the industry down to third place. Compared with the same period last year, investment fell 32% to €179 million. So too did deal flow, by 55% to 31 deals completed. Despite attracting an 85% share of all healthcare-related investment for the quarter, the biopharmaceuticals sector still experienced a slight decrease of 4% in investment from the same period a year ago, raising €153 million through 21 deals. Investments in the medical devices and equipment sector slumped to €14 million in seven deals during the third quarter, a drop of 86% in amount invested and 76% in deal flow.
Software Most Popular Sector For European Venture Investment In Third Quarter This Year
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
Every recommendation goes through 3 layers of intense scrutinyquantitative, fundamental and technical analysisto maximize profit potential and minimize risk.
Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.